557ddcdd-4eb7-41fd-9e5c-5680401301b5.jpg

Answer the assignment

Reading File

Finding Sources

Searching PubMed

"gestational diabetes mellitus"[MeSH Terms] AND "screening"[MeSH Terms]

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive information from multiple authoritative textbooks to write a thorough assignment. Let me compose the answer.

Assignment: Gestational Diabetes Mellitus - Clinical Case

A 30-year-old woman, G2P1, at 20 weeks gestation - Prenatal Examination

Pre-pregnancy BMI: 29 kg/m² | Weight gain: 7 kg | Father recently diagnosed with diabetes

Introduction

This patient presents with a clinically important question: should she be tested for gestational diabetes mellitus (GDM)? Her concern is timely and well-founded. This assignment addresses the pathophysiology of GDM, her individual risk factors, current screening guidelines, diagnostic criteria, management principles, and maternal-fetal outcomes.

What is Gestational Diabetes Mellitus?

GDM is defined as glucose intolerance - or any abnormality in glucose levels - that is first diagnosed during pregnancy and is not clearly pre-existing diabetes. It is estimated to affect 5-9% of all pregnancies (using the standard two-step US diagnostic procedure) and represents one of the most common medical complications of pregnancy.

The underlying pathophysiology mirrors that of type 2 diabetes mellitus (T2DM). Pregnancy is a state of progressively increasing insulin resistance, predominantly driven by placentally-produced hormones - most notably human placental lactogen (HPL) - which increase with placental mass and advancing gestational age. Most women compensate with increased pancreatic insulin secretion. In a subset who cannot adequately compensate, blood glucose rises, resulting in GDM. GDM is effectively a form of T2DM precipitated by the metabolic stress of pregnancy.

- Goldman-Cecil Medicine, Textbook of Family Medicine 9e

Assessing This Patient's Risk Factors

This patient has multiple risk factors for GDM:

Risk Factor	This Patient
BMI ≥ 25 kg/m² (overweight/obese)	BMI = 29 kg/m² (overweight, approaching obese)
Age ≥ 25 years	Age = 30 years
Family history of type 2 diabetes	Father recently diagnosed with diabetes
Multiparous	Second pregnancy
Excessive weight gain in current pregnancy	7 kg gained at 20 weeks

The USPSTF and ACOG specifically identify the following as high-risk groups: women who are obese, older than 25 years, have a family history of type 2 diabetes or GDM, or belong to certain ethnic groups (Hispanics, Native Americans, Asians, African Americans). This patient meets at least three of the first four criteria.

- Textbook of Family Medicine 9e, Swanson's Family Medicine Review

Should She Be Tested for Diabetes? - Answering Her Question

Yes, she should be tested - and her concern is clinically valid.

Her pre-pregnancy BMI of 29 kg/m², age above 25, and a newly diagnosed first-degree relative with diabetes each independently justify GDM screening. Her 7 kg weight gain at 20 weeks (slightly above expected for overweight women) adds further concern.

When to Screen

Standard practice (USPSTF, ACOG) recommends universal GDM screening between 24 and 28 weeks of gestation for all pregnant women. The USPSTF issued a Grade B recommendation for screening asymptomatic pregnant women after 24 weeks of gestation.

However, for high-risk women - those with obesity, prior GDM, glucosuria, or a strong family history - earlier screening (at the first prenatal visit) is indicated. If the early screen is negative, it should be repeated at 24-28 weeks.

This patient, at 20 weeks, would be appropriate for early screening given her risk profile, with repeat testing at 24-28 weeks if initial screening is negative.

- Textbook of Family Medicine 9e; Goldman-Cecil Medicine; Creasy & Resnik's Maternal-Fetal Medicine

Screening and Diagnostic Criteria

Two-Step Approach (Standard in the US - ACOG)

Step 1: 50-g Oral Glucose Challenge Test (GCT) - Non-fasting

Administer 50 g glucose orally
Measure plasma glucose at 1 hour
Abnormal (positive screen): glucose ≥ 140 mg/dL (some centers use ≥ 130 mg/dL for higher sensitivity)
If positive, proceed to Step 2

Step 2: 100-g 3-hour Oral Glucose Tolerance Test (OGTT) - Fasting

Patient should have at least 3 days of adequate carbohydrate intake before the test
Fast overnight prior to the test
Administer 100 g glucose; venous glucose measured at fasting, 1h, 2h, and 3h
Two or more abnormal values confirm the diagnosis of GDM

Time Point	NDDG Threshold	Carpenter & Coustan Threshold
Fasting	105 mg/dL	95 mg/dL
1 hour	190 mg/dL	180 mg/dL
2 hours	165 mg/dL	155 mg/dL
3 hours	145 mg/dL	140 mg/dL

One-Step Approach (IADPSG/WHO - used internationally)

A single 75-g 2-hour OGTT at 24-28 weeks (fasting):

Threshold	Value
Fasting plasma glucose	≥ 92 mg/dL (5.1 mmol/L)
1-hour post-load	≥ 180 mg/dL (10.0 mmol/L)
2-hour post-load	≥ 153 mg/dL (8.5 mmol/L)

Only one abnormal value is needed for diagnosis with this approach.

- Creasy & Resnik's Maternal-Fetal Medicine; Textbook of Family Medicine 9e

Additional Assessment: Could She Already Have Pre-existing (Undiagnosed) Diabetes?

Because many women do not receive diabetes screening prior to pregnancy, it is important to distinguish between GDM and pre-existing (pregestational) diabetes mellitus. A diagnosis of overt diabetes in pregnancy is confirmed by:

Fasting plasma glucose ≥ 126 mg/dL, or
Random plasma glucose ≥ 200 mg/dL, or
HbA1c ≥ 6.5%

Given her pre-pregnancy BMI of 29 and a diabetic first-degree relative, checking an early fasting glucose or HbA1c at the current visit (20 weeks) is reasonable to rule out pre-existing undiagnosed T2DM.

Management of GDM (If Diagnosed)

First-line: Diet and Exercise

Carbohydrate-restricted diet (complex carbohydrates, distributed across 3 meals + 3 daily snacks)
Regular moderate exercise (e.g., brisk walking 20-30 minutes, 3 times per week)

Blood Glucose Monitoring

Fasting each morning
1 hour after each meal begins (target: < 140 mg/dL) OR 2 hours after each meal (target: < 120 mg/dL)
Fasting target: < 95 mg/dL

Pharmacotherapy (if diet/exercise fails)

Insulin is the preferred pharmacological agent in pregnancy
- Typically 0.7-1.0 units/kg/day in divided doses
- Two-thirds of dose given before breakfast (2:1 NPH:regular); one-third before dinner (1:1 regular:NPH)
Metformin and glyburide have been used but have limitations; insulin remains the gold standard

- Goldman-Cecil Medicine; Swanson's Family Medicine Review

Maternal and Fetal Complications of GDM

Fetal/Neonatal Risks

Macrosomia (large-for-gestational-age infant) - leading complication of GDM
Shoulder dystocia and birth trauma
Neonatal hypoglycemia
Increased risk of childhood and adult obesity and T2DM

Maternal Risks

Increased risk of operative delivery (cesarean section)
Preeclampsia
Long-term: 50% risk of developing T2DM within 10 years of GDM diagnosis
Cardiovascular disease risk in the future

- Goldman-Cecil Medicine; Braunwald's Heart Disease; Textbook of Family Medicine 9e

Postpartum Follow-up

All women with GDM should undergo a 75-g 2-hour OGTT at 6-12 weeks postpartum to screen for persistent glucose abnormality. If normal, the woman should be rescreened every 1-3 years given the high risk of future T2DM. Lifestyle interventions (healthy diet, physical activity, weight management) significantly reduce this risk.

Summary and Clinical Recommendation

This patient's question is clinically appropriate and should be answered affirmatively:

Yes, she should be tested for gestational diabetes. She carries three major risk factors - overweight BMI (29 kg/m²), age above 25 years, and a first-degree relative with newly diagnosed diabetes. While routine universal screening occurs at 24-28 weeks, her risk profile warrants early screening at the current visit (20 weeks), with standard repeat screening at 24-28 weeks if this is negative. Early identification and treatment of GDM significantly reduces fetal macrosomia, birth trauma, and other adverse outcomes, and allows timely maternal lifestyle intervention to reduce long-term T2DM risk.

References:

Textbook of Family Medicine, 9th Edition (Rakel), Chapter 20
Goldman-Cecil Medicine, International Edition - Endocrine Disorders in Pregnancy
Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice
Swanson's Family Medicine Review - GDM and Shoulder Dystocia
Katzung's Basic and Clinical Pharmacology, 16th Edition

This is a shared conversation. Sign in to Orris to start your own chat.